Robert Plenge MD, PhD

Bristol Myers Squibb

Robert is Senior Vice President, Research & Early  Development and Head of Immunology, Cardiovascular, & Fibrosis Thematic Research Center (ICF TRC) and Translational Medicine (TM) at Bristol Myers Squibb (BMS). Within the ICF TRC, Robert is responsible for the strategic vision, implementation, and partnership of novel therapies from discovery through proof-of-concept clinical trials for immunologic, CV and fibrotic diseases. Within TM, Robert is responsible for diagnostics and late development translational plans across all therapeutic areas at BMS, including oncology and hematology. Together,

HLTH does not sell or provide any personal data (including email, phone, address) to any third parties and we never will. Any communication that pretends to be HLTH or any third parties selling purported lists, discounted rooms, or any product/services are NOT AFFILIATED with HLTH and are to be considered FRAUD.

Upcoming Event Dates

2024 | ViVE: Feb 25-28; HLTH Europe: Jun 17-20; HLTH US: Oct 20-23

2025 | ViVE: Feb 16-19; HLTH US: Oct 19-22

2026 | HLTH US: Nov 15-18

2027 | HLTH US: Oct 17-20

© 2024 HLTH, INC. All Rights Reserved